Theranexus (EPA:ALTHX)

BRIEF

published on 04/28/2026 at 19:05, 4 days 22 hours ago

THX Pharma: Annual Results and Cash Flow Statement

2025 Annual Results THX Pharma Biocodex Cash Flow 2026 Strategic Licenses
BRIEF

published on 04/28/2026 at 19:05, 4 days 22 hours ago

THX Pharma Strengthens Financial Position in 2025

Financial Results Cash Position Neurological Diseases THX Pharma Biocodex Partnership
PRESS RELEASE

published on 04/28/2026 at 19:00, 4 days 22 hours ago

THX Pharma Publishes Its 2025 Annual Results, Cash Position as of March 31, 2026, and Provides a Business Update
THX Pharma announces annual results, cash position, and strategic partnerships, including Biocodex agreement. Financial stability secured. Focus on clinical development and commercialization of TX01 and Batten-1

Strategic Partnership Financial Stability Neurological Diseases THX Pharma Biocodex
BRIEF

published on 03/25/2026 at 18:50, 1 month 8 days ago

Theranexus publishes its letter to shareholders

Shareholders Biopharmaceutical Neurology Theranexus Drugs
BRIEF

published on 03/25/2026 at 18:50, 1 month 8 days ago

THX Pharma Publishes Letter to Shareholders

Innovation Shareholders Licensing Agreements Neurological Diseases THX Pharma
PRESS RELEASE

published on 03/25/2026 at 18:45, 1 month 8 days ago

THX Pharma Announces the Publication of its Letter to Shareholders
THX Pharma (Theranexus) announces the publication of a letter to shareholders regarding its innovative treatments for rare neurological diseases. Company details and contact information included

Shareholders Biopharmaceutical Theranexus Neurological Diseases THX Pharma
BRIEF

published on 02/25/2026 at 18:05, 2 months 5 days ago

THX Pharma increases the resources of its liquidity contract

Liquidity Contract Euronext Growth Biopharmaceutical Financial Resources THX Pharma
BRIEF

published on 02/19/2026 at 18:05, 2 months 11 days ago

THX Pharma strengthens its financial position as of December 31, 2025

Treasury Partnership Batten-1 TX01 Biocodex
BRIEF

published on 02/19/2026 at 18:05, 2 months 11 days ago

THX Pharma Announces Strong Cash Position at Year-End

Cash Position THX Pharma Biocodex Agreement Batten-1 Program TX01 Development
PRESS RELEASE

published on 02/19/2026 at 18:00, 2 months 11 days ago

THX Pharma Reports Its Cash Position as of December 31, 2025
THX Pharma (Theranexus) announces cash position of €7.8 million as of Dec 31, 2025. Pro forma cash position reaches €21.7 million with incoming payment from Biocodex agreement. Company focused on rare neurological diseases treatments development

Cash Position Rare Neurological Diseases Therapeutic Solutions THX Pharma Biocodex Agreement

1 2 ... 8

Published on 05/02/2026 at 21:00, 20 hours 49 minutes ago

GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 16 hours ago

Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 16 hours ago

CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 17 hours ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 17 hours ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

View all ACCESSWIRE

Published on 05/03/2026 at 04:45, 13 hours 4 minutes ago

GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 1 day 2 hours ago

Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 22 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 1 day 23 hours ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 2 days ago

Key Figures 30.04.2026

View all EQS

Published on 04/30/2026 at 20:00, 2 days 21 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 2 days 22 hours ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 2 days 22 hours ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 2 days 23 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 2 days 23 hours ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News